<DOC>
	<DOCNO>NCT00145535</DOCNO>
	<brief_summary>Use Titanium Sapphire laser laser trabeculoplasty reduce intraocular pressure patient poorly control intraocular pressure maximally tolerate medical therapy prior fail laser trabeculoplasty .</brief_summary>
	<brief_title>SOLX Titanium Sapphire Laser Trabeculoplasty</brief_title>
	<detailed_description>This multi-center , outpatient study assess equivalence Titanium Sapphire laser ( TiSaLT ) Argon laser ( ALT ) ability reduce IOP patient primary open angle glaucoma eye poorly control IOP maximally tolerate medication and/or prior fail glaucoma surgery . Approximately 120 patient enrol study , approximately equal number patient enrol investigational site . The investigational site accrue patient poorly control open-angle glaucoma maximal tolerate medical therapy and/or patient previously fail laser trabeculoplasty . One half eye randomize treatment Argon laser ( ALT ) concurrent control group half treat Titanium Sapphire ( TiSaLT ) laser .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<criteria>Clinical Diagnosis Open Angle Glaucoma Patient age 18 year old , 2 sight eye . Eye treat average IOP great equal 22 mmHg , measure 2 pretreatment visit . Eye treat either exhibit : poorly control open angle glaucoma maximal tolerate medical therapy OR poorly control open angle glaucoma fail previous laser trabeculoplasty ( 180Â° available treat previous ALT ; treat previous SLT ) Patients eligible enrollment follow exclusion criterion meet : Eye treat follow : 1. evidence glaucoma openangle glaucoma ; 2. severe paracentral generalize field defect ; 3. ocular condition preclude adequate visualization treatment trabecular meshwork . 4. prior glaucoma surgery laser trabeculoplasty peripheral iridotomy . Patient mental impairment he/she could understand protocol position provide write informed consent . Patient pregnant . Patient might require ocular surgery within 6month followup period . Patient medical history suggest potential complication TiSaLT . Having concurrent treatment systemic steroid .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Glaucoma</keyword>
	<keyword>Glaucoma , open angle</keyword>
	<keyword>Intraocular Pressure</keyword>
	<keyword>Trabeculoplasty</keyword>
	<keyword>laser</keyword>
	<keyword>laser , surgery</keyword>
</DOC>